AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Telmibite-MT 40+50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Razenta pharmaceuticals Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telmibite-MT 40+50 Tablet ER

Telmibite-MT 40+50 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use enhances survival rates following a heart attack. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continue treatment as prescribed; even asymptomatic hypertension necessitates ongoing medication to prevent worsening. Lifestyle modifications—regular exercise, weight management, and a balanced diet—complement this therapy. Strictly adhere to your doctor's instructions. Potential side effects include headache, weakness, lightheadedness, hypotension, hyperkalemia, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be required. Inform your doctor of any pre-existing liver or kidney conditions, and pregnant or breastfeeding individuals should seek medical counsel before starting this medication. Disclose all current medications, especially those for hypertension or heart disease.

Primary Ingredients of Telmibite-MT 40+50 Tablet ER

No information provided. Please provide the text you wish me to rewrite.

Uses of Telmibite-MT 40+50 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmibite-MT 40+50 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Telmibite-MT 40+50 Tablet ER with a meal.

Common Side effects of Telmibite-MT 40+50 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telmibite-MT 40+50 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telmibite-MT 40+50 Tablet ER with a meal.

How Telmibite-MT 40+50 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telmibite-MT 40+50 Extended-Release tablets, work together to reduce high blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Telmibite-MT 40+50 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmibite-MT 40+50 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmibite-MT 40+50 tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmibite-MT 40+50 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

The extended-release Telmibite-MT 40+50 tablet is considered safe for patients with impaired renal function. No dosage modification is necessary for Telmibite-MT 40+50 extended-release tablets in this patient population.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Telmibite-MT 40+50 Extended-Release tablets. Dosage modification of Telmibite-MT 40+50 Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Telmibite-MT 40+50 Tablet ER :

Should you forget to take a Telmibite-MT 40+50 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Telmibite-MT 40+50 Tablet ER

LabelValue
Developing Habits No.
Type of Therapy HEART

FAQs on Telmibite-MT 40+50 Tablet ER

Yes, Telmibite-MT 40+50 Tablet ER Succinate may cause dizziness, especially when standing up quickly from a lying or sitting position. To minimize dizziness or fainting, rise slowly from a seated or reclined position.
Telmibite-MT 40+50 Tablet ER Succinate works best when combined with healthy lifestyle choices. Quitting smoking significantly reduces your risk of heart attack and stroke. Weight management, through diet and exercise, is also crucial. A balanced diet rich in fruits and vegetables, along with regular physical activity, strengthens your heart and lowers heart attack risk.
Continue taking Telmibite-MT 40+50 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause severe complications, including heart attack and stroke.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Telmibite-MT 40+50 Tablet...
126
MRP 146
13% off